Analysis of tumoral, stromal and glycolitic markers in the response basal cell carcinoma and Bowen disease to photodynamic therapy in real life
Open Access
- 10 December 2024
- journal article
- research article
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 51, 104442
Abstract
No abstract availableKeywords
Funding Information
- Government of Aragon Department of Education Culture and Sports
- Ministerio de Economía y Competitividad (FIS PI21/00953)
- Direction Générale de l’Armement
- Carlos III Health Institute (PI21/00315)
This publication has 28 references indexed in Scilit:
- Photodynamic Therapy by Glucose Transporter 1-Selective Light InactivationACS Omega, 2022
- The Warburg Effect: How Does it Benefit Cancer Cells?Trends in Biochemical Sciences, 2016
- Cellular Intrinsic Factors Involved in the Resistance of Squamous Cell Carcinoma to Photodynamic TherapyJournal of Investigative Dermatology, 2014
- Unravelling mechanisms of p53-mediated tumour suppressionNature Reviews Cancer, 2014
- Mutant p53 in Cancer: New Functions and Therapeutic OpportunitiesCancer Cell, 2014
- Photodynamic therapy (PDT) using topically applied δ-aminolevulinic acid (ALA) for the treatment of malignant skin tumorsPhotodiagnosis and Photodynamic Therapy, 2004
- Control of oncogenesis and cancer therapy resistanceBritish Journal of Cancer, 2004
- Photodynamic Therapy Using Topical Methyl Aminolevulinate vs Surgeryfor Nodular Basal Cell CarcinomaArchives of Dermatology, 2004
- Photodynamic Therapy for Basal Cell Carcinoma: Effect of Tumor Thickness and Duration of Photosensitizer Application on ResponseArchives of Dermatology, 1998
- Repetitive photodynamic therapy with topical δ-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumoursJournal of Photochemistry and Photobiology B: Biology, 1995